open access

Vol 8, No 12 (2007): Practical Diabetology
Original articles (submitted)
Published online: 2008-02-28
Get Citation

Improvement of cardiovascular autonomic function after 2 years of good glycaemic control in diabetes type 1

Przemysław Witek
Diabetologia Praktyczna 2007;8(12):459-468.

open access

Vol 8, No 12 (2007): Practical Diabetology
Original articles (submitted)
Published online: 2008-02-28

Abstract

INTRODUCTION. The autonomic cardiovascular neuropathy in diabetes is associated with an increased risk of sudden death. The aim of the study was the prospective analysis of the difference in autonomic function tests during 2 year follow-up regard to the level of metabolic compensation.
MATERIAL AND METHODS. Ninety eight patients with diabetes type 1 were examined at baseline, after 12 and 24 months for autonomic dysfunction, by using the computer device ProSciCard. Parameters of the following tests were analysed: heart rate variability at 5 min rest (time and frequency domain analysis), deep breathing, lying-to-standing heart rate changes, Valsalva manoeuvre, lying-to-standing blood pressure changes, sustained handgrip. Patients were divided into 3 groups: well, intermediate and poorly compensated. The divisions were made using the mean HbA1c, taken every 6 months during the study.
RESULTS. The significant differences for the following parameters between groups were found: at the initial visit - no differences; after 12 months for SDRRR, CVR, RMSSDR, HFR, SDRRDB, RMSSDDB, EINDEX, PioΔDSCTK1; after 24 months for HRR, SDRRR, RMSSDR, PioΔDSCTK1. After 12 and 24 months the best values were found in well controlled subjects and the worst values were in poorly controlled ones.
CONCLUSIONS: Metabolic compensation of diabetes is a very important factor determining the course of cardiovascular neuropathy. Good metabolic control of the disease can improve autonomic function tests, whereas poor control leads to an inevitable deterioration of the autonomic nervous system.

Abstract

INTRODUCTION. The autonomic cardiovascular neuropathy in diabetes is associated with an increased risk of sudden death. The aim of the study was the prospective analysis of the difference in autonomic function tests during 2 year follow-up regard to the level of metabolic compensation.
MATERIAL AND METHODS. Ninety eight patients with diabetes type 1 were examined at baseline, after 12 and 24 months for autonomic dysfunction, by using the computer device ProSciCard. Parameters of the following tests were analysed: heart rate variability at 5 min rest (time and frequency domain analysis), deep breathing, lying-to-standing heart rate changes, Valsalva manoeuvre, lying-to-standing blood pressure changes, sustained handgrip. Patients were divided into 3 groups: well, intermediate and poorly compensated. The divisions were made using the mean HbA1c, taken every 6 months during the study.
RESULTS. The significant differences for the following parameters between groups were found: at the initial visit - no differences; after 12 months for SDRRR, CVR, RMSSDR, HFR, SDRRDB, RMSSDDB, EINDEX, PioΔDSCTK1; after 24 months for HRR, SDRRR, RMSSDR, PioΔDSCTK1. After 12 and 24 months the best values were found in well controlled subjects and the worst values were in poorly controlled ones.
CONCLUSIONS: Metabolic compensation of diabetes is a very important factor determining the course of cardiovascular neuropathy. Good metabolic control of the disease can improve autonomic function tests, whereas poor control leads to an inevitable deterioration of the autonomic nervous system.
Get Citation

Keywords

diabetes mellitus type 1; diabetic autonomic neuropathy; glycaemic control

About this article
Title

Improvement of cardiovascular autonomic function after 2 years of good glycaemic control in diabetes type 1

Journal

Clinical Diabetology

Issue

Vol 8, No 12 (2007): Practical Diabetology

Pages

459-468

Published online

2008-02-28

Bibliographic record

Diabetologia Praktyczna 2007;8(12):459-468.

Keywords

diabetes mellitus type 1
diabetic autonomic neuropathy
glycaemic control

Authors

Przemysław Witek

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

 

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl